en-USen-GB
  • Virtual Global Workshop 11-13 May 2020
    Virtual Global Workshop 11-13 May 2020
  • Tokyo 2-3 December 2019
    Tokyo 2-3 December 2019
  • Zurich 28-30 October 2019
    Zurich 28-30 October 2019
  • Peapack 14-16 October 2019
    Peapack 14-16 October 2019
  • Brussels 15-17 May 2019
    Brussels 15-17 May 2019
  • Danbury 8-10 April 2019
    Danbury 8-10 April 2019

WHO WE ARE

The eClinical Forum is a global network of peers. It provides a non‐competitive environment for innovation, learning and collaboration in clinical research.


News from the eCF

Login to also view news for Members.

Netherlands initiative to assess electronic health record systems using eCF eSRA tool

Partnering for Success

  • 17 February 2016
  • Author: Webmaster
  • Number of views: 13744
  • 0 Comments
Netherlands initiative to assess electronic health record systems using eCF eSRA tool

NL initiative to assess electronic health record systems using eCF eSRA tool

The Dutch Clinical Trial Foundation (DCTF) has endorsed an EHR working group committed to the implementation of one uniform tool for the validation of electronic health record (EHR) systems used at clinical research sites within the Netherlands. The group consists of representatives from several pharmaceutical companies, CROs and hospitals, and is chaired by Martijn Griep, Johnson & Johnson Regional QC Manager, coordinated by Dana De Beuckelaer-Dournez from the University of Antwerp.

After considerable research and discussion with national stakeholders, the working group has chosen to use the eSRA (eSource-Readiness Assessment) program to harmonize the review of the EHR systems and to prove compliance against appropriate clinical research regulations and guidances. eSRA is provided for free by the eClinical Forum (a non-profit, non-commercial discussion/action group comprised of members of the Pharmaceutical and Clinical Research Services industry).This tool is intended to make the clinical research process more efficient, while furthering the use of EHR records for clinical research. Clinical research sites are often asked by their clinical trial sponsors to complete questionnaires regarding their EHR system. With each sponsor having its own questionnaire, completing a different form for each sponsor can be very time consuming. By using the eSRA system to complete a standard form, they can do it once and provide it to all their sponsors. And, since eSRA is based on the EMA and FDA regulations, the resulting report is appropriate to share with regulators.

The EHR working group started a pilot in three big hospitals to assess their systems using eSRA. Ellen Rusch, scientific member Scientific Institution, Martini Hospital Groningen and one of the members of the working group, was the first to complete the process.. She reported that the website that hosts the eSRA system was easy to use without any training.  She worked with her IT support staff, and together they were able to complete the assessment in only 30 minutes! “We do about 50-80 trials each year and we are receiving a new sponsor questionnaire to complete about every 2 weeks. Each sponsor has their own form with questions worded differently, so it is very time consuming to work through each questionnaire. Each sponsor form takes an hour or more to read the new form, determine the answers and file the form. Then we must wait for the sponsor to review the form and sometimes re-work if there are any errors, etc. Some pharma-provided forms can be rather long, even though they all seem to ask the same questions, just in a different format each time. By doing the eSRA assessment once, knowing that it has been completed correctly, and providing the resulting report to the sponsors, we will save a lot of time. In addition, by registering for notifications, the eSRA system will notify us if any clinical research regulations have changed that we should be aware of.”

Martijn Griep, J&J, says “The completion of an eSRA assessment by the Martini Hospital is an important first step towards the registration of more sites and towards gaining the interest of large EHR system vendors to cooperate. By having the EHR vendors complete a pre-assessment of their systems, eSRA can be even more efficient, as these vendor assessments will be used as a resource for our clinical research sites when they complete their site assessments, so that all sites in the NL can use eSRA to assess their systems. Our vision is that all clinical research sites in the Netherlands will be assessed using eSRA and to facilitate eSRA recognition by all sponsors and regulators. We are very grateful to the eClinical Forum for providing this free tool.”

The EHR working group is planning further roll out to more clinical research sites in the NL and mutual acceptance by pharmaceutical companies such that eSRA can replace their own questionnaires. They believe this will avoid duplication of efforts by the completion of various forms and it will contribute to more efficient and reliable data collection in clinical trials.

 

Print
Tags:
Rate this article:
No rating

Theme picker

Not a member?
Visit the Membership page to learn 
How To Become a Member
(Join the eClinical Forum and learn how to leverage existing and emerging technologies for electronic clinical trials. Access an eClinical community, member-only knowledge, events and forums)

«July 2020»
MonTueWedThuFriSatSun
293012345
678
7/8/2020 UTC
102

Birds-of-a-Feather Webinar: Real-world data (RWD) and real-world evidence (RWE)

According to the FDA’s website, “Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions.”  And a recent survey by the eClinical Forum showed that most respondents believe that RWD and RWE will become much more important in clinical research over the next few years.  As a result, many questions have arisen regarding the use cases, data sources, quality of these sources, regulatory guidance documents and so on. The goal of this “Birds of a Feather” session is to present some basic information on these topics and to present a few case examples to illustrate how RWD and RWE are playing an increasingly important role in research. 

Read more
9101112
13141516171819
20212223
7/23/2020 UTC
105

Technology Showcase: eClinical Solutions -- Automating the Clinical Data Pipeline for Enhanced Data Review & Analytics

There has been a dramatic increase in clinical data types, sources and systems in recent years enabling new insights into patient experiences while also presenting challenges in consolidating, standardizing and analyzing these new data streams.  The tools for centralizing, integrating, mapping and analyzing data have not kept pace with research and are causing cycle time delays and require numerous manual processes.  This technology showcase will describe how new platforms like the elluminate Clinical Data Platform are automating the ingestion of data from numerous eClinical systems and sources, enabling faster data mapping and standardization, supporting risk based data review and advancing both clinical and operational analytics.  

Presented by Sheila Rocchio and Sam Parnell of eClinical Solutions.

Read more
242526
272829303112
3456789

Upcoming events Events RSSiCalendar export

  • Birds-of-a-Feather Webinar: Real-world data (RWD) and real-world evidence (RWE) (7/8/2020 UTC)
    7/8/2020 UTC
    102

    Birds-of-a-Feather Webinar: Real-world data (RWD) and real-world evidence (RWE)

    According to the FDA’s website, “Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions.”  And a recent survey by the eClinical Forum showed that most respondents believe that RWD and RWE will become much more important in clinical research over the next few years.  As a result, many questions have arisen regarding the use cases, data sources, quality of these sources, regulatory guidance documents and so on. The goal of this “Birds of a Feather” session is to present some basic information on these topics and to present a few case examples to illustrate how RWD and RWE are playing an increasingly important role in research. 

    Read more
  • Technology Showcase: eClinical Solutions -- Automating the Clinical Data Pipeline for Enhanced Data Review & Analytics (7/23/2020 UTC)
    7/23/2020 UTC
    105

    Technology Showcase: eClinical Solutions -- Automating the Clinical Data Pipeline for Enhanced Data Review & Analytics

    There has been a dramatic increase in clinical data types, sources and systems in recent years enabling new insights into patient experiences while also presenting challenges in consolidating, standardizing and analyzing these new data streams.  The tools for centralizing, integrating, mapping and analyzing data have not kept pace with research and are causing cycle time delays and require numerous manual processes.  This technology showcase will describe how new platforms like the elluminate Clinical Data Platform are automating the ingestion of data from numerous eClinical systems and sources, enabling faster data mapping and standardization, supporting risk based data review and advancing both clinical and operational analytics.  

    Presented by Sheila Rocchio and Sam Parnell of eClinical Solutions.

    Read more
  • Birds-of-a-Feather Round Table Discussion: U.S. National Patient Identifier (NPI) and its Impact to Clinical Trials (8/18/2020 UTC)
    8/18/2020 UTC
    106

    Birds-of-a-Feather Round Table Discussion: U.S. National Patient Identifier (NPI) and its Impact to Clinical Trials

    Presenter/Facilitator:  Ken Light, Clinscape

    In 1996, HIPAA legislation called for the development of a national patient identifier system that would give each person in the United States a permanently assigned, unique number to be used across the entire spectrum of the national healthcare system.   That project was never funded by congress, but just last year (June, 2019) Congress voted to appropriate $99 billion dollars to an HHS bill that included creation of a National Patient Identifier.

    Ken will review this topic, and oversee a group dialog around the benefits, challenges, and impact related to healthcare and clinical trials.   

    Read more
  • eCF Autumn 2020 Virtual Workshop Planned (10/12/2020 - 10/16/2020 UTC)
    10/12/2020 - 10/16/2020 UTC
    103

    eCF Autumn 2020 Virtual Workshop Planned

    Following the success of our Spring Virtual Workshop (see article below), we are now planning for an Autumn 2020 Virtual Workshop. This will replace face-to-face meetings in Asia, Europe and North America due to continued concern for our members safety during the Covid-19 pandemic. It is our hope that we will be able to resume face-to-face workshops in 2021 as our members have expressed their desire to get back to "getting together" in person once it is appropriate to do that, as they say "nothing can replace the networking and comeraderie of an eCF face-to-face meeting".

    The Autumn 2020 Virtual Workshop will build on our success, learnings, and suggestions for improvement from the Spring Virtual Workshop. We plan to have more interactive sessions, more sessions that are regional-based to allow a better time-of-day for most participants, have some global sessions to allow for the valuable global interaction, and spread it over a full week with a few hours/day. We are currently in the planning stage and welcome suggestions to discussion topics via info@eclinicalforum.org as well as considering all suggestions submitted with the Spring workshop evaluations.

    Please mark your calendars for Oct 12-16 2020 ... and stay tuned for more detailed information as we develop it!

    Read more

This form...